Drug delivery partnerships now available for world’s strongest broad-spectrum antibiotic

(1888PressRelease) Partnerships are now available for new topical antibiotic that kills all Gram-positive and Gram-negative bacteria pathogens that have been available for testing.

Minneapolis, MN, USA - The availability of drug delivery partnerships was announced this week at the LifeScience Alley Conference & Expo in Minneapolis, MN, on December 8. These partnership opportunities are based on the development of a new drug delivery formulation by Phillips Company, an FDA-registered Native American owned pharmaceutical manufacturer located in Oklahoma.

Read more on Drug delivery partnerships now available for world’s strongest broad-spectrum antibiotic…

New Antibiotic Designed To Overcome MRSA Bacteria

(1888PressRelease) A new topical antibiotic formulation, designed to overcome bacterial drug-resistance, is now available Over The Counter (OTC). Known as Tetracycline-ABC, it kills the most drug-resistant and deadly bacteria such as Staph, MRSA and Acinetobacter.

Read more on New Antibiotic Designed To Overcome MRSA Bacteria…

World’s Most Broad-Spectrum Antibiotic Available OTC

(1888PressRelease) A new topical antibiotic formulation, known as Tetracycline-ABC kills the most drug-resistant and the most deadly bacteria (Staph, MRSA and Acinetobacter), which cause community or hospital acquired infections.

The availability of a new topical antibiotic formulation, known as Tetracycline-ABC, was announced today. The new liquid antibiotic is available as an OTC drug by Phillips Company, an FDA-registered pharmaceutical manufacturer.

Read more on World’s Most Broad-Spectrum Antibiotic Available OTC…